1. Home
  2. Browse by Author

Browsing by Author "Balahoroglu, R."

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Conference Object
    Efficacy and Safety of Rectal Ibuprofen for Ductus Arteriosus Closure in Very Low Birth Weight Infants
    (Springer, 2016) Demir, N.; Peker, E.; Ece, I.; Balahoroglu, R.; Tuncer, O.
  • Loading...
    Thumbnail Image
    Conference Object
    Oxidative Stress in Rats During Exposure To Cigarette Smoke and After Smoking Cessation
    (Wiley-blackwell, 2016) Donder, A.; Balahoroglu, R.; Huyut, Z.; Yildirim, S.; Dulger, H.; Ilhan, F.; Yilmaz, A.
  • Loading...
    Thumbnail Image
    Article
    Plasma Amino Acid Profile in Autism Spectrum Disorder (Asd)
    (verduci Publisher, 2016) Bala, K. A.; Dogan, M.; Mutluer, T.; Kaba, S.; Aslan, O.; Balahoroglu, R.; Kocaman, S.
    OBJECTIVE: In our study, we aimed to reveal pathophysiologic mechanisms in ASD by comparing plasma amino acid levels between patients and healthy controls while considering vitamin B12 and D levels. PATIENTS AND METHODS: The study included 21 patients aged 2-18 years-old who were followed with a diagnosis autism spectrum disorder (ASD) and 21 age and sex-matched healthy children from our outpatient clinic as control group. RESULTS: The study included 42 children and adolescents aged 2-18 years-old (19 girls and 23 boys). There were no significant differences in terms of body weight and height between the groups. We found significant differences in levels of ammonium, phosphoethanolamine, histidine, homocysteine, carnosine, methionine, cystathionine, cyste0ine, threonine, 3-methyl histidine and phenylalanine/tyrosine ratio between patient and control groups. Both vitamin B12 and D were significantly lower in the ASD group compared to controls. In the variance analysis with vitamin B12 and D as covariates, significant differences persisted for only phosphoethanolamine (p=0.04), cystathionine (p<0.001), cystine (p=0.006) and threonine (p=0.02). CONCLUSIONS: Further studies are needed on the amino acids that show variations in children with ASD in order to reveal their role in the etiology and therapeutic use in ASD.
  • Loading...
    Thumbnail Image
    Conference Object
    Protective Effects of Antioxidants on the Experimental Liver and Kidney Toxicity in Mice
    (Amer Assoc Clinical Chemistry, 2006) Balahoroglu, R.; Dulger, H. H.; Ozbek, H.; Bayram, I.; Sekeroglu, M. R.